Clinical and biochemical efficacy of minocycline in nonsurgical periodontal therapy: A randomized controlled pilot study

Journal of Clinical Pharmacology

Volumn 51, Issue 6, 2011, Pages 915-922

  Basegmez, Cansu ^a   Berber, Lacin ^b   Yalcin, Funda ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Faculty of Dentistry   (Turkey)

Author keywords

gingival crevicular fluid; matrix metalloproteinase 8; Minocycline; prostaglandin E2

Indexed keywords

MINOCYCLINE; NEUTROPHIL COLLAGENASE; PLACEBO; PROSTAGLANDIN E2;

ADULT; ARTICLE; CHRONIC PERIODONTITIS; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CONTROLLED STUDY; CORRELATIONAL STUDY; DRUG CAPSULE; DRUG DOSE REDUCTION; ENZYME IMMUNOASSAY; FEMALE; GINGIVITIS; HUMAN; MALE; MEDICAL PARAMETERS; PATIENT COMPLIANCE; PILOT STUDY; PROBING DEPTH; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RELATIVE ATTACHMENT LEVEL; SULCUS BLEEDING INDEX; TOOTH PLAQUE; TREATMENT DURATION;

ADULT; ANTI-BACTERIAL AGENTS; DENTAL PLAQUE INDEX; DINOPROSTONE; FEMALE; GINGIVAL CREVICULAR FLUID; HUMANS; MALE; MATRIX METALLOPROTEINASE 8; MINOCYCLINE; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL INDEX; PERIODONTITIS; PILOT PROJECTS;

EID: 79955788939     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1177/0091270010373929     Document Type: Article

References (37)

1. Grenier D, Plamondon P, Sorsa T, et al. Inhibition of proteolytic, serpinolytic and progelatinase-B activation activities of periodontopathogens by doxycycline and non-antimicrobial chemically modified tetracycline derivatives. J Periodontol. 2002 ; 73: 79-85 (Pubitemid 34213462)
2. Caton JG, Ciancio SG, Blieden TM, et al. Subantimicrobial dose doxycycline as an adjunct to scaling and root planing: post-treatment effects. J Clin Periodontol. 2001 ; 28: 782-789 (Pubitemid 33761320)
3. Page RC, Offenbacher S, Schroeder HE, Symour GJ, Kornman KS. Advances in the pathogenesis of periodontitis: summary of developments, clinical implications and future directions. Periodontol 2000. 1997 ; 14: 216-248 (Pubitemid 127601178)
4. Genco RJ. Host responses in periodontal diseases: current concepts. J Periodontol. 1992 ; 63: 338-355
5. Eley BM, Cox SW. Advances in periodontal diagnosis: potential inflammatory and immune markers. Br Dent J. 1998 ; 184: 220-223 (Pubitemid 128529142)
6. Golub LM, Lee H, Greenwald RA, et al. A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and bone-type collagenase in gingival crevicular fluid during adult periodontitis. Inflamm Res. 1997 ; 4: 310-319 (Pubitemid 27399588)
7. Golub LM, Ryan ME, Williams RC. Modulation of the host response in the treatment of periodontitis. Dent Today. 1998 ; 17: 102 108-106 109
8. Goodson JM, Dewhirst FE, Brunetti A. Prostaglandin E2 levels and human periodontal disease. Prostaglandins. 1974 ; 6: 81-85
9. Golub L, Sorsa T, Lee HM, et al. Doxycycline inhibits neutrophil (PMN)-type matrix metalloproteinases in human adult periodontitis gingiva. J Clin Periodontol. 1995 ; 21: 100-109
10. Ryan ME, Ramamurthy N, Golub LM. Matrix metalloproteinase and their inhibition in periodontal treatment. Curr Opin Periodontol. 1996 ; 3: 85-96
11. Preshaw PM, Lauffart B, Brown P, Zak E, Heasman PA. Effects of ketorolac tromethamine mouthrinse (0.1%) on crevicular fluid prostaglandin E2 concentrations in untreated chronic periodontitis. J Periodontol. 1998 ; 69: 777-783 (Pubitemid 28363455)
12. Preshaw PM, Lauffart B, Zak E, Jeffcoat MK, Barton I, Heasman PA. Progression and treatment of chronic adult periodontitis. J Periodontol. 1999 ; 70: 1209-1220
13. Ryan ME, Golub LM. Modulation of matrix metalloproteinase activities in periodontics as a treatment strategy. Periodontol 2000. 2000 ; 24: 226-238
14. Caton JG. Evaluation of Periostat for patient management. Compendium. 1999 ; 20: 451-462
15. Ciancio SG, Mather ML, McMullen JA. An evaluation of minocycline in patients with periodontal disease. J Periodontol. 1980 ; 51: 530-534
16. Ciancio SG, Slots J, Reynolds HS, Zambon JJ, McKenna JD. The effect of short-term administration of minocycline HCl on gingival inflammation and subgingival microflora. J Periodontol. 1982 ; 53: 557-561 (Pubitemid 13242888)
17. Freeman E, Ellen RP, Thompson G, Weinberg SE, Song M, Lazarus RH. Gingival crevicular fluid concentration and side effects of minocycline: a comparison of two dose regimens. J Periodontol. 1992 ; 63: 13-18
18. Golub LM, Lee HM, Lehrer G, Nemiroff A, McNamara TF, Kaplan R. Minocycline reduces gingival collagenolytic activity during diabetes: preliminary observations and a proposed new mechanism of action. J Periodont Res. 1983 ; 18: 516-524
19. Golub LM, Wolff M, Lee HM, et al. Further evidence that tetracyclines inhibit collagenase activity in human crevicular fluid and from other mammalian sources. J Periodont Res. 1985 ; 20: 12-23 (Pubitemid 15101424)
20. Golub LM, Ciancio S, Ramamurthy NS, Leung M, McNamara TF. Low-dose doxycycline therapy: effect on gingival and crevicular fluid collagenase activity in humans. J Periodont Res. 1990 ; 25: 321-330
21. Golub LM, Ramamurthy NS, McNamara TF, Greenwald RA, Rifkin BR. Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs. Crit Rev Oral Biol Med. 1991 ; 2: 297-322
22. Rifkin BR, Vernillo AT, Golub LM. Blocking periodontal disease progression by inhibiting tissue destructive enzymes: a potential therapeutic role for tetracyclines and their chemically-modified analogs. J Periodontol. 1993 ; 64 (suppl 8). 819-827 (Pubitemid 23278153)
23. Ingman T, Sorsa T, Suomalainen K, Halinen S, Lindy O, Lauhio A. Tetracycline inhibition and the cellular source of collagenase in gingival crevicular fluid in different periodontal diseases: a review article. J Periodontol. 1993 ; 64: 82-88 (Pubitemid 23090196)
24. Golub LM, Wolff M, Roberts S, Lee HM, Leung M, Payonk GS. Treating periodontal diseases by blocking tissue-destructive enzymes. J Am Dent Assoc. 1994 ; 125: 163-169
25. Ng vW, Bissada NF. Clinical evaluation of systemic doxycycline and ibuprofen administration as an adjunctive treatment for adult periodontitis. J Periodontol. 1998 ; 69: 772-776 (Pubitemid 28363454)
26. McCulloch CAG, Birek P, Overall C, Aitken S, Lee W, Kulkarni G. Randomized controlled trial of doxycycline in prevention of recurrent periodontitis in high risk patients: antimicrobial activity and collagenase inhibition. J Clin Periodontol. 1990 ; 17: 616-622 (Pubitemid 20329611)
27. Nip LH, Uitto VJ, Golub LM. Inhibition of epithelial cell amtrix metalloproteinases by tetracyclines. J Periodont Res. 1993 ; 28: 379-385 (Pubitemid 23282035)
28. Sorsa T, Ding Y, Salo T, Lauhio A, Teronen O, Ingman T. Effects of tetracyclines on neutrophil, gingival and salivary collagenases: a functional and western-blot assessment with special references to their cellular sources in periodontal diseases. Ann NY Acad Sci. 1994 ; 732: 112-131
29. Krady JK, Basu A, Allen CM, Xu Y, LaNoue KF, Gardner TW. Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. Diabetes. 2005 ; 54: 1559-1565 (Pubitemid 40586690)
30. Silness J, Löe H. Periodontal disease in pregnancy, II: correlation between oral hygiene and periodontal condition. Acta Odontol Scand. 1964 ; 22: 121
31. Mühleman HR, Son S. Gingival bleeding, a leading symptom in initial gingivitis. Helv Odontol Acta. 1971 ; 15: 107
32. Offenbacher S, Farr DH, Goodson JM. Measurement of prostaglandin E2 in crevicular fluid. J Clin Periodontol. 1981 ; 8: 359-367
33. Offenbacher S, Odle BM, Gray RC, Van Dyke TE. Crevicular fluid prostaglandin E2 levels as a measure of periodontal disease status of adult and juvenile periodontitis patients. J Periodont Res. 1984 ; 19: 1-13
34. Lowenguth RA, Greenstein G. Clinical and microbiological response to nonsurgical mechanical periodontal therapy. Periodontol 2000. 1995 ; 9: 14-22
35. Herrera D, Sanz M, Jepsen S, Needleman I, Roldan S. A systematic review on the effect of systemic antimicrobials as an adjunct to scaling and root planing in periodontitis patients. J Clin Periodontol. 2002 ; 29 (suppl 3). 136-159 (Pubitemid 41719448)
36. Haffajee AD, Socransky SS, Gunsolley JC. Systemic anti-infective periodontal therapy: a systematic review. Ann Periodontol. 2003 ; 8: 115-181
37. Söder B. Neutrophil elastase activity, levels of prostaglandin E2, and matrix metalloproteinase-8 in refractory periodontitis sites in smokers and nonsmokers. Acta Odontol Scand. 1999 ; 57: 77-82